Stéphane Nancey

8.4k total citations
170 papers, 3.3k citations indexed

About

Stéphane Nancey is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Stéphane Nancey has authored 170 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Genetics, 97 papers in Epidemiology and 53 papers in Immunology. Recurrent topics in Stéphane Nancey's work include Inflammatory Bowel Disease (113 papers), Microscopic Colitis (80 papers) and Immunodeficiency and Autoimmune Disorders (23 papers). Stéphane Nancey is often cited by papers focused on Inflammatory Bowel Disease (113 papers), Microscopic Colitis (80 papers) and Immunodeficiency and Autoimmune Disorders (23 papers). Stéphane Nancey collaborates with scholars based in France, United States and Belgium. Stéphane Nancey's co-authors include Bernard Flourié, Gilles Boschetti, Xavier Roblin, Laurent Peyrin‐Biroulet, Dominique Kaiserlian, Stéphane Paul, Driffa Moussata, Nicolas Williet, David Laharie and Émilie Del Tedesco and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Stéphane Nancey

159 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Stéphane Nancey	2.0k	1.7k	893	891	459	170	3.3k
Marcus Harbord	2.2k 1.1×	1.6k 1.0×	637 0.7×	843 0.9×	392 0.9×	26	3.0k
J F Colombel	2.2k 1.1×	1.7k 1.0×	797 0.9×	1.4k 1.5×	389 0.8×	148	3.6k
Bruce Yacyshyn	1.8k 0.9×	1.3k 0.8×	654 0.7×	948 1.1×	857 1.9×	78	3.5k
Thomas Ochsenkühn	2.8k 1.4×	1.9k 1.2×	1.5k 1.6×	1.6k 1.8×	520 1.1×	99	5.0k
Gianluca M. Sampietro	2.1k 1.0×	1.5k 0.9×	801 0.9×	1.4k 1.6×	288 0.6×	82	3.5k
Themistocles Dassopoulos	1.5k 0.7×	1.1k 0.6×	1.6k 1.8×	700 0.8×	949 2.1×	66	4.0k
Julia Seiderer	1.3k 0.6×	710 0.4×	1.4k 1.6×	617 0.7×	413 0.9×	53	2.9k
Florian Beigel	1.3k 0.6×	968 0.6×	1.6k 1.8×	502 0.6×	467 1.0×	68	3.4k
John Mansfield	1.7k 0.8×	1.1k 0.7×	1.0k 1.1×	796 0.9×	433 0.9×	60	2.8k
Dirk J. de Jong	2.0k 1.0×	1.6k 1.0×	1.5k 1.7×	970 1.1×	716 1.6×	119	4.4k

Countries citing papers authored by Stéphane Nancey

Since Specialization

Citations

This map shows the geographic impact of Stéphane Nancey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Nancey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Nancey more than expected).

Fields of papers citing papers by Stéphane Nancey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Nancey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Nancey. The network helps show where Stéphane Nancey may publish in the future.

Co-authorship network of co-authors of Stéphane Nancey

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Nancey. A scholar is included among the top collaborators of Stéphane Nancey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Nancey. Stéphane Nancey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reenaers, Cathérine, Maria Nachury, David Laharie, et al.. (2024). DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort. Journal of Crohn s and Colitis. 18(Supplement_1). i117–i117. 1 indexed citations

Reenaers, Cathérine, Maria Nachury, David Laharie, et al.. (2024). Impact of Histological Remission for Predicting Clinical Relapse in Crohn’s Disease: A Post Hoc Analysis of the Prospective STORI Cohort. Journal of Crohn s and Colitis. 19(4). 1 indexed citations

Bouguen, Guillaume, Laure Gossec, Guillaume Bonnaud, et al.. (2024). Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study. BioDrugs. 38(6). 867–878. 2 indexed citations

Roblin, Xavier, Stéphane Nancey, Konstantinos Papamichael, et al.. (2023). Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 18(5). 679–685. 18 indexed citations

Fuméry, Mathurin, Stéphane Nancey, Jérôme Filippi, et al.. (2023). Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study. Alimentary Pharmacology & Therapeutics. 57(11). 1290–1298. 2 indexed citations

Nancey, Stéphane, Mélanie Serrero, Ludovic Caillo, et al.. (2023). Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study. Clinics and Research in Hepatology and Gastroenterology. 47(5). 102107–102107. 3 indexed citations

Buisson, Anthony, Harry Sokol, Nassim Hammoudi, et al.. (2022). Role of adherent and invasive Escherichia coli in Crohn’s disease: lessons from the postoperative recurrence model. Gut. 72(1). 39–48. 33 indexed citations

Boschetti, Gilles, Bruno Pereira, Bernard Flourié, et al.. (2021). Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy. Alimentary Pharmacology & Therapeutics. 53(12). 1289–1299. 33 indexed citations

Buisson, Anthony, Stéphane Nancey, David T. Rubin, et al.. (2021). Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United European Gastroenterology Journal. 9(5). 552–560. 34 indexed citations

10.

Laharie, David, Stéphane Nancey, Xavier Hébuterne, et al.. (2020). Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease. Digestive and Liver Disease. 52(7). 740–744. 10 indexed citations

11.

Bourrier, Anne, Maria Nachury, Stéphane Nancey, et al.. (2020). Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients. Alimentary Pharmacology & Therapeutics. 51(7). 719–727. 46 indexed citations

12.

Williet, Nicolas, Lieven Pouillon, Manoel de Carvalho, et al.. (2018). Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study. Alimentary Pharmacology & Therapeutics. 47(7). 906–912. 87 indexed citations

13.

Auzolle, Claire, Stéphane Nancey, My‐Linh Tran‐Minh, et al.. (2018). Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study. Alimentary Pharmacology & Therapeutics. 48(9). 924–932. 63 indexed citations

14.

Gagnière, Charlotte, Anne Bourrier, Philippe Seksik, et al.. (2018). Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Alimentary Pharmacology & Therapeutics. 48(7). 713–722. 7 indexed citations

15.

Roblin, Xavier, Gilles Boschetti, Nicolas Williet, et al.. (2017). Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial. Alimentary Pharmacology & Therapeutics. 46(2). 142–149. 89 indexed citations

16.

Martineau, Chloé, Bernard Flourié, Pauline Wils, et al.. (2017). Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study. Alimentary Pharmacology & Therapeutics. 46(11-12). 1077–1084. 23 indexed citations

17.

Boschetti, Gilles, Émilie Bardel, Sophie Collardeau‐Frachon, et al.. (2016). Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3⁺Regulatory T Cells but Impairs Their Conversion from CD4⁺T Cells. Journal of Crohn s and Colitis. 11(1). 105–117. 29 indexed citations

18.

Atreya, Raja, Stuart Bloom, Franco Scaldaferri, et al.. (2015). OP015. Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for efficacy in moderate to severe Ulcerative Colitis. Journal of Crohn s and Colitis. 9(suppl 1). S9–S9. 1 indexed citations

19.

Boschetti, Gilles, Souad Assaad, B. Balme, et al.. (2015). A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease. Gut. 65(2). 295–295. 5 indexed citations

20.

Boschetti, Gilles, et al.. (2014). P233 Early measurement of fecal calprotectin after intestinal resection is useful to predict postoperative recurrence in patients with Crohn's disease. Journal of Crohn s and Colitis. 8. S159–S159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact